These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9741497)

  • 1. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.
    Abizaid A; Kornowski R; Mintz GS; Hong MK; Abizaid AS; Mehran R; Pichard AD; Kent KM; Satler LF; Wu H; Popma JJ; Leon MB
    J Am Coll Cardiol; 1998 Sep; 32(3):584-9. PubMed ID: 9741497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting.
    Ahmed JM; Hong MK; Mehran R; Dangas G; Mintz GS; Pichard AD; Satler LF; Kent KM; Wu H; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Oct; 36(4):1186-93. PubMed ID: 11028469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
    Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
    Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study.
    Schofer J; Schlüter M; Rau T; Hammer F; Haag N; Mathey DG
    J Am Coll Cardiol; 2000 May; 35(6):1554-9. PubMed ID: 10807460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
    Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results after drug-eluting stent implantation in diabetic patients according to diabetic treatment.
    Voudris V; Karyofillis P; Thomopoulou S; Doulaptsis C; Manginas A; Pavlides G; Cokkinos DV
    Hellenic J Cardiol; 2011; 52(1):15-22. PubMed ID: 21292603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems.
    Laham RJ; Carrozza JP; Berger C; Cohen DJ; Kuntz RE; Baim DS
    J Am Coll Cardiol; 1996 Oct; 28(4):820-6. PubMed ID: 8837554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of patient age on acute and late clinical outcomes following Palmaz-Schatz coronary stent implantation.
    Abizaid AS; Mintz GS; Abizaid A; Saucedo JF; Mehran R; Pichard AD; Kent KM; Satler LF; Leon MB
    Am J Cardiol; 2000 Feb; 85(3):338-43. PubMed ID: 11078303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.
    Van Belle E; Bauters C; Hubert E; Bodart JC; Abolmaali K; Meurice T; McFadden EP; Lablanche JM; Bertrand ME
    Circulation; 1997 Sep; 96(5):1454-60. PubMed ID: 9315531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial.
    Giannini F; Latib A; Jabbour RJ; Costopoulos C; Chieffo A; Carlino M; Montorfano M; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(1):4-9. PubMed ID: 28011243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group.
    Savage MP; Fischman DL; Schatz RA; Teirstein PS; Leon MB; Baim D; Ellis SG; Topol EJ; Hirshfeld JW; Cleman MW
    J Am Coll Cardiol; 1994 Nov; 24(5):1207-12. PubMed ID: 7930240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of the clinical and angiographic evolution of diabetic and nondiabetic patients treated by conventional angioplasty versus stent implantation in native coronary arteries].
    Navarro del Amo LF; Iñiguez Romo A; Ibargollín Hernández R; García Belenguer R; Fernández Rozas I; Rodríguez Carreras RC
    Rev Esp Cardiol; 2000 Feb; 53(2):172-8. PubMed ID: 10734748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and angiographic outcome after Palmaz-Schatz stent implantation guided by intravascular ultrasound.
    Hall P; Nakamura S; Maiello L; Almagor Y; Gaglione A; Goldberg SL; Tobis JM; Martini G; Tucci G; Di Maggio M
    J Invasive Cardiol; 1995; 7 Suppl A():12A-22A. PubMed ID: 10155111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome.
    Silva JA; Ramee SR; White CJ; Collins TJ; Jenkins JS; Nunez E; Zhang S; Jain SP
    Am Heart J; 1999 Sep; 138(3 Pt 1):446-55. PubMed ID: 10467194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bailout coronary stenting without anticoagulation or intravascular ultrasound guidance: acute and six-month angiographic results in a series of 120 consecutive patients.
    Antoniucci D; Valenti R; Santoro GM; Bolognese L; Taddeucci E; Trapani M; Santini A; Fazzini PF
    Cathet Cardiovasc Diagn; 1997 May; 41(1):14-9. PubMed ID: 9143760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients.
    van der Hoeven BL; Pires NM; Warda HM; Putter H; Quax PH; Schalij MJ; Jukema JW
    Int J Cardiol; 2008 Feb; 124(2):166-71. PubMed ID: 17408773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation.
    Tarantini G; Briguori C; Stankovic G; Takagi T; Corvaja N; Di Mario C; Colombo A
    Ital Heart J; 2003 Dec; 4(12):843-9. PubMed ID: 14976848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry.
    Valdés Chavarri M; Bethencourt A; Pinar E; Gomez A; Portales JF; Pomar F; Calvo I; López-Minguez J; Valdesuso R; Moreu J; Martínez A; Nammas W
    Heart Vessels; 2012 Mar; 27(2):151-8. PubMed ID: 21448677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes and coronary stent implantation: experience from a reference center in interventional cardiology].
    Schaan BD; Quadros A; Sarmento-Leite R; Gottschall CA
    Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):38-45. PubMed ID: 16628273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.